The previous page is sending you to https://in.reuters.com/article/health-coronavirus-gilead-sciences/gilead-prices-covid-19-drug-remdesivir-at-2340-per-patient-in-developed-nations-idINKBN2401ER?il=0.

 If you do not want to visit that page, you can return to the previous page.